SALT LAKE CITY, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2024. “For the third quarter of 2024, I am pleased with our strong financial results, including total revenue of $76.4 million and Adjusted EBITDA of $7.3 million, with these results exceeding the mid-point of our quarterly guidance on each m ...

Core Viewpoint - Health Catalyst (HCAT) has been upgraded to a Zacks Rank 2 (Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling pressure that affects stock prices [4]. Company Performance and Outlook - The recent upgrade for Health Catalyst indicates a positive outlook for its earnings, suggesting potential buying pressure and an increase in stock price [3][5]. - Health Catalyst is projected to earn $0.36 per share for the fiscal year ending December 2024, reflecting a year-over-year increase of 140% [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7]. - Health Catalyst's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].

I recommended a buy rating for Health Catalyst (NASDAQ: HCAT ) when I wrote about it in March, as I was confident that HCAT could achieve its FY28 targets by executing growth strategies that have a stronger I consider an investment ideal if it performs its core business in a sector projected to experience structural (organic) growth in excess of GDP growth over the next 5-10 years; profits from sustainable competitive advantages that translate into attractive unit economics; In the hands of competent, ethic ...

SALT LAKE CITY, Aug. 27, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Wisconsin Statewide Health Information Network, Inc. (WISHIN), an independent not-for-profit organization dedicated to bringing the benefits of widespread, secure, interoperable health information technology to patients and caregivers throughout Wisconsin, has selected to expand its multi-year ...

Core Insights - Health Catalyst has successfully completed the acquisition of Lumeon Limited, a digital health company focused on automated care orchestration [1][2] - The acquisition aims to enhance Health Catalyst's data analytics capabilities and improve clinical care through Lumeon's technology [2][4] - Health Catalyst expects to leverage Lumeon's presence in the UK to expand into new international markets [3] Company Overview - Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations, utilizing a cloud-based platform powered by over 100 million patient records [5] - The company is committed to enabling data-informed healthcare improvements and enhancing clinical, financial, and operational outcomes for its clients [5] Strategic Goals - The integration of Lumeon's Care Orchestration technology with Health Catalyst's Ignite AI platform is expected to provide healthcare organizations with data-driven insights and automate clinical actions [4] - This acquisition is anticipated to strengthen Health Catalyst's focus on clinical improvement and support its Tech-Enabled Managed Services partnerships [2][4]

SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expanded partnership with Contexture, a nonprofit, regional health information exchange organization that works to drive health data interoperability. Contexture supports the flow of health information between thousands of physician practices, hospitals, long-term care facilities, labs, radiology ...

Health Catalyst (HCAT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 33.33%. A quarter ago, it was expected that this provider of data analytics for the health care industry would post earnings of $0.03 per share when it actually produced earnings of $0.05, delivering a surprise of ...

"This financing is an important milestone for Health Catalyst and its shareholders. The Credit Facility not only assists with refinancing our existing convertible notes, but also provides flexibility and additional non-dilutive capital for us to continue to proactively pursue meaningful organic and inorganic growth opportunities, and to continue to act as a consolidation platform for our clients, integrating compelling technologies within our five areas of focus, which we believe positions us well to create ...

Healthcare portfolios include telehealth stocks, notably after the COVID-19 pandemic, which increased global telemedicine usage, demonstrating their importance for lockdowns and other social isolation scenarios. A Dana-Farber Cancer Institute study also indicated that telemedicine may considerably cut cancer treatment greenhouse gas emissions. Under these circumstances, telehealth stocks will only gain favor with the investing community. That's why we'll explore three undervalued telehealth stocks, each wit ...

SALT LAKE CITY, June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer. Oncology providers and life science researchers use Carevive's flagship platform and/or ...